The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 343:1411-1413 November 9, 2000 Number 19
NextNext

The Emergence of Kaposi's Sarcoma–Associated Herpesvirus (Human Herpesvirus 8)

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Pauk, J.
-Related Article
 by Luppi, M.
-PubMed Citation
The concept of emerging "new" pathogens is somewhat misnamed, since these pathogens are usually old infections that have newly adapted to social and technological changes. Such is the case for Kaposi's sarcoma–associated herpesvirus, also referred to as human herpesvirus 8 (HHV-8), which was first described in 1994 and is the subject of two articles, one by Luppi et al.1 and one by Pauk et al.,2 in this issue of the Journal.

HHV-8 is closely related to the Epstein–Barr virus (human herpesvirus 4) and infects CD19+ B cells as well as the endothelial-derived spindle cells of Kaposi's sarcoma lesions.3 In addition . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.